Time from last immunity event against infection during Omicron-dominant period in MalaysiaMulticenter Study Published on 2023-03-012023-07-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] Healthcare workers Hybrid immunity Malaysia omicron Previous SARS-CoV-2 infection vaccination. [DOI] 10.1016/j.ijid.2022.12.025 PMC 바로가기 [Article Type] Multicenter Study
Prevalence and Predictors of Anxiety among Stable Hospitalized COVID-19 Patients in MalaysiaArticle Published on 2022-12-292023-07-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), [키워드] Anxiety COVID-19 hospitalised Malaysia mental health. [DOI] 10.3390/ijerph20010586 PMC 바로가기
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infectionDelta 및 Omicron SARS-CoV-2 감염에 대한 동종 및 이종 BNT162b2, CoronaVac 및 AZD1222 추가 백신 접종의 실제 효과Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] AZD1222 BNT162b2 booster booster vaccination conducted CoronaVac country COVID-19 COVID-19 vaccines Delta demonstrated effective Effectiveness Evidence evidence of Heterologous heterologous booster homologous homologous booster Immune escape inactivated Malaysia National omicron percentage points recipient SARS-CoV-2 SARS-COV-2 infection the SARS-CoV-2 vaccination Vaccine vaccine effectiveness. Vaccines Viral viral variant [DOI] 10.1080/22221751.2022.2072773 PMC 바로가기 [Article Type] Article
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia말레이시아에서 BNT162b2 백신을 접종한 의료 종사자의 COVID-19 획기적인 감염 및 체액성 면역 반응Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] 95% CI affected age Anti-S1 Anti-spike antibody Antibody Response antibody titres association Asymptomatic Asymptomatic individuals blood sample Blood samples BNT162b2 booster vaccination breakthrough Breakthrough infection breakthrough infections collected COVID-19 COVID-19 infection delta variant detectable domain geometric mean geometric mean titre GMT HCWs healthcare healthcare worker Healthcare workers humoral humoral immune response Humoral immunity IgG IgG assay individual individuals Infection investigated Malaysia not different notable outcome Participants prospective cohort study Protein response significantly significantly higher Support symptomatic the antibody response vaccination Vaccine vaccine doses vaccine. waned was measured [DOI] 10.1080/22221751.2022.2065936 PMC 바로가기 [Article Type] Article
SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic waveArticle Published on 2022-12-012023-07-10 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] COVID-19 Delta genome surveillance Malaysia omicron SARS-CoV-2. [DOI] 10.1016/j.ijid.2022.10.044 PMC 바로가기
Malaysian Disaster Medicine Research: A Bibliographic Study of Publication TrendsReview Published on 2022-12-012023-07-10 Journal: Prehospital and Disaster Medicine [Category] COVID19(2023년), [키워드] disaster disaster education Disaster medicine disaster research Disaster training emergency medicine Malaysia prehospital care. [DOI] 10.1017/S1049023X22002187 PMC 바로가기 [Article Type] Review
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial재조합 인터페론 무장 융합 단백질 백신(V-01)을 사용한 SARS-CoV-2에 대한 이종 부스팅의 효능: 무작위, 이중 맹검 및 위약 대조 3상 시험Clinical Trial Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 임상, 진단, [키워드] adverse event antibody assigned booster clinical trial common adverse event conducted COVID-19 vaccine COVID-19 vaccines dose double-blind dramatic increase Efficacy elicit eligible fatigue Fever fusion protein groups headache healthy Heterologous heterologous boosting Humoral immunity Identifier Immunity inactivated Inactivated vaccine Inactivated Vaccines Inc injection injection site intention-to-treat principle Malaysia Mild-to-moderate Neutralizing Neutralizing antibodies occurred Older omicron Omicron variant over Pain participant Participants Placebo placebo-controlled primary endpoint Randomized Randomly receive regimen robust Safe SARS-CoV-2 SARS-COV-2 infection second dose Serious Adverse Events subunit Subunit vaccine Subunit vaccine. Surveillance symptomatic SARS-CoV-2 infection the epidemic titre Trial Trial registration V-01 Vaccine vaccine efficacy variant virus-neutralizing antibodies was measured were assessed [DOI] 10.1080/22221751.2022.2088406 PMC 바로가기 [Article Type] Clinical Trial
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patientsArticle Published on 2022-10-012022-11-16 Journal: The lancet. Psychiatry [Category] COVID19(2023년), SARS, 변종, [키워드] 1:1 Adults Affect age Alpha Analysis Anxiety Anxiety Disorder B.1.1.529 B.1.1.7 B.1.617.2 baseline Brain Bulgaria children cognitive Cohort cohort of patient cohorts cohorts of patient collected COVID-19 death rate Dementia Demographic factors diagnose diagnosed diagnosed with COVID-19 Diagnosis diagnosis of COVID-19 died disorder disorders Electronic health record epilepsy female Follow-up follow-up period foundation greater hazard ratio health-care health-care system help higher risk hospital HRs incidence increased risk India indicate individual Insomnia International ischaemic stroke less Malaysia male matching neurological Older other respiratory infections outcome outcomes Oxford Parkinsonism Pathogenesis Patient primary care profile proportion Psychiatric psychiatric diagnose psychiatric diagnosis psychiatric disorder reached recorded remained representing respiratory infection response retrospective cohort retrospective cohort study returned risk risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant Seizure Seizures severe COVID-19 illness significantly Spain stratified study period sustained Taiwan trajectory USA vaccination variant variants was done while with COVID-19 Wolfson [DOI] 10.1016/S2215-0366(22)00260-7 PMC 바로가기
Antibody dynamics post-Comirnaty and CoronaVac vaccination in MalaysiaArticle Published on 2022-09-192022-11-15 Journal: Scientific Reports [Category] SARS, 진단, 치료기술, [키워드] analyzed antibody blood sample clinical trial CoronaVac correlation detectable East effective IgG IgM independent magnitude Malaysia mitigate moderate neutralizing antibody pandemic progression recipient recipients responses Result SARS-CoV-2 vaccination second dose serum serum vitamin D significantly higher subset the patient vaccination Vaccine Vaccines [DOI] 10.1038/s41598-022-19776-3 PMC 바로가기
COVID-19 preventive behavior among university students in Southeast Asia: Effects of knowledge, concern, awareness, and perceived riskArticle Published on 2022-09-092022-11-15 Journal: Frontiers in Public Health [Category] SARS, 치료기술, [키워드] age age and gender Analysis applied approach collected coronavirus disease Coronavirus disease 2019 COVID-19 Data analysis Effect effective Factors fraction global health globe Infectious disease Interaction knowledge Malaysia measure MGA multiple group analysis pandemic Pandemics Partial Perceived risk Precaution preventive behavior. public health reduce retrieved risk significantly Spread study outcomes Surveillance threat Threats variables was performed [DOI] 10.3389/fpubh.2022.958021 PMC 바로가기